Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Quantitative Swept-Source Optical Coherence Tomography Angiography Indicators of Neurovascular Dysfunction in Alzheimer Disease.

JAMA ophthalmology·2026
Same author

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Clinical Associations and Possible Risk Factors for Affective Neuropsychiatric Symptoms in Older Adults With and Without Cognitive Impairment.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

Affective neuropsychiatric symptom metrics in the National Alzheimer's Coordinating Center dataset.

Journal of Alzheimer's disease : JAD·2026
Same author

Message From the Editors to Our Reviewers: 2025.

Neurology. Genetics·2026
Same journal

Characterizing Onset Limit and Surgical Outcome Factors in Type II Focal Cortical Dysplasia-Related Epilepsy.

Neurology. Clinical practice·2026
Same journal

Efficacy and Safety of Perampanel in Patients With Brain Tumor-Related Epilepsy: A Systematic Review and Meta-Analysis.

Neurology. Clinical practice·2026
Same journal

Patient-Reported Symptom Burden in Individuals With Parkinson Disease.

Neurology. Clinical practice·2026
Same journal

Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity.

Neurology. Clinical practice·2026
Same journal

Clinical Differentiation of Self-Limited Epilepsy With Autonomic Seizures (Panayiotopoulos Syndrome) and Childhood Migraine.

Neurology. Clinical practice·2026
Same journal

The National Association of Epilepsy Centers Accreditation Criteria Should Include Care for People With Functional/Dissociative Seizures.

Neurology. Clinical practice·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K

Neurogenetics: Five new things.

Suman Jayadev1, Corrine O Smith1, Thomas D Bird1

  • 1Departments of Neurology (SJ, COS, TDB) and Medicine (COS, TDB), University of Washington, Seattle; and Geriatric Research Education and Clinical Center (TDB), VA Puget Sound Health Care System, Seattle, Washington.

Neurology. Clinical Practice
|February 15, 2018
PubMed
Summary
This summary is machine-generated.

Molecular genetics advances enable precise identification of genetic mutations for neurological diseases like Huntington disease (HD). This facilitates accurate genetic testing and novel therapeutic strategies for previously incurable neurogenetic conditions.

More Related Videos

Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication
03:53

Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication

Published on: November 17, 2023

1.6K
Monitoring Changes in the Intracellular Calcium Concentration and Synaptic Efficacy in the Mollusc Aplysia
09:51

Monitoring Changes in the Intracellular Calcium Concentration and Synaptic Efficacy in the Mollusc Aplysia

Published on: July 15, 2012

11.4K

Related Experiment Videos

Last Updated: Feb 14, 2026

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K
Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication
03:53

Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication

Published on: November 17, 2023

1.6K
Monitoring Changes in the Intracellular Calcium Concentration and Synaptic Efficacy in the Mollusc Aplysia
09:51

Monitoring Changes in the Intracellular Calcium Concentration and Synaptic Efficacy in the Mollusc Aplysia

Published on: July 15, 2012

11.4K

Area of Science:

  • Neurology
  • Molecular Genetics
  • Genomic Medicine

Background:

  • Clinical neurology has been significantly impacted by advances in molecular genetics.
  • Historically, Huntington disease (HD) risk assessment relied on linkage analysis.
  • Current genetic technologies allow for definitive identification of HD mutations and hundreds of other genetic disorders.

Purpose of the Study:

  • To highlight the transformative impact of molecular genetics on clinical neurology.
  • To discuss the evolution of genetic testing from linkage analysis to whole genome/exome sequencing.
  • To emphasize the role of genetic discoveries in developing new treatments for neurogenetic diseases.

Main Methods:

  • Review of historical and current genetic analysis techniques.
  • Discussion of advancements in whole genome and exome sequencing.
  • Integration of genetic information with protein function and therapeutic development.

Main Results:

  • Certainty in identifying the Huntington disease (HD) mutation and numerous other disease-causing mutations.
  • Anticipation of one-step genetic interrogation for a wider spectrum of diseases via whole genome/exome sequencing.
  • Development of innovative treatment approaches based on identified genes and proteins.

Conclusions:

  • Genetic testing provides definitive diagnoses for a growing number of neurogenetic diseases.
  • New technologies are paving the way for effective treatments for once-incurable conditions.
  • Neurologists face the challenge of interpreting complex genetic data to guide patient care and treatment.